Adtalem (ATGE) Form 144: Insider Sale Planned for 08/27/2025

Rhea-AI Filing Summary

Adtalem Global Education Inc. (ATGE) filing under Rule 144 notifies a proposed sale of 18,392 common shares with an aggregate market value of $2,486,888.99, to occur approximately on 08/27/2025 on the NYSE. The filing shows the securities sold were acquired through restricted stock vesting and performance stock units: 5,132 shares on 08/25/2024, 1,296 shares on 11/09/2023, and 11,964 shares on 08/25/2024, with payment characterized as services rendered.

The notice also reports a prior sale by Lisa Wardell of 12,900 shares on 08/21/2025 for gross proceeds of $1,714,465.47. Several standard filer and issuer contact fields in the form are blank or marked as test/live, and the signature/notice date details are not provided in the text.

Positive

• Complete mapping of acquisitions to the shares proposed for sale—the 18,392 shares to be sold equal the sum of disclosed vesting and PSU amounts (5,132 + 1,296 + 11,964).
• Transaction details provided include approximate sale date (08/27/2025), exchange (NYSE), and aggregate market value ($2,486,888.99).
• Prior sale disclosed (12,900 shares on 08/21/2025 for $1,714,465.47), which improves visibility into recent insider liquidity.

Negative

• Filer and issuer contact fields are blank or unpopulated in the provided content, limiting verification of the submitting party.
• Notice date and signature details are not present in the extract, reducing clarity on the filing's timing and attestation.
• Some form sections appear template-like (e.g., LIVE TEST toggle and empty submission contact), suggesting the filing may be incomplete as provided.

Insights

Securities Analyst

TL;DR: Rule 144 sale of 18,392 shares disclosed; acquisitions were via vesting and PSUs, prior 12,900-share sale reported.

The filing transparently links the shares proposed for sale to specific grant events and vesting dates, showing the total planned disposition equals the sum of recent equity award vestings. The aggregate value reported provides a clear mark for the proposed transaction. Missing filer contact and certain form fields limit immediate verification and tracking of trading-plan specifics. No earnings or material operational disclosures are included, so investor impact is transaction-level and administrative.

Corporate Governance Expert

TL;DR: Disclosure is routine for insider-derived awards; incomplete filer/contact details reduce transparency.

The form documents that the securities were acquired as compensation (restricted stock and PSUs) and that sales occurred recently, consistent with typical insider liquidity events. However, the absence of populated filer CIK/contact and the lack of an explicit notice date or signature details in the content provided constrain assessment of procedural compliance and timing relative to any 10b5-1 trading plans. This is a procedural filing rather than a corporate-governance event affecting control.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	18392	2486888.99	35955712	08/27/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/25/2024	Restricted stock vesting under a registered plan	Issuer			5132	08/25/2024	Services Rendered
Common	11/09/2023	Restricted stock vesting under a registered plan	Issuer			1296	11/09/2023	Services Rendered
Common	08/25/2024	Performance Stock Units	Issuer			11964	08/25/2024	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Lisa Wardell 233 South Wacker Drive Suite 800 Chicago IL 60606	Common	08/21/2025	12900	1714465.47

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the ATGE Form 144 propose to sell and when?

The notice proposes sale of 18,392 common shares with an approximate sale date of 08/27/2025 on the NYSE.

How were the 18,392 shares acquired according to the filing?

The filing shows acquisition via restricted stock vesting (5,132 on 08/25/2024 and 1,296 on 11/09/2023) and performance stock units (11,964 on 08/25/2024).

What is the aggregate market value of the shares to be sold?

The aggregate market value reported is $2,486,888.99 for the 18,392 shares.

Did the filer report any recent sales of the issuer's stock?

Yes. The filing lists a prior sale by Lisa Wardell of 12,900 shares on 08/21/2025 for gross proceeds of $1,714,465.47.

Are there any missing details in the provided Form 144 extract?

Yes. Several submission contact and filer identification fields and an explicit notice/signature date are not populated in the provided content.